Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
28 déc. 2017 09h30 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...